Suppr超能文献

长期干细胞给药的潜在治疗效果:对多囊肾病/ Mhm(Cy / +)大鼠基因谱和肾功能的影响。

Potential Therapeutic Effects of Long-Term Stem Cell Administration: Impact on the Gene Profile and Kidney Function of PKD/Mhm (Cy/+) Rats.

作者信息

Nardozi Daniela, Palumbo Stefania, Khan Arif Ul Maula, Sticht Carsten, Bieback Karen, Sadeghi Samar, Kluth Mark Andreas, Keese Michael, Gretz Norbert

机构信息

Medical Research Center, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer, 68167 Mannheim, Germany.

Vascular Surgery, University Hospital Mannheim, 68167 Mannheim, Germany.

出版信息

J Clin Med. 2022 May 5;11(9):2601. doi: 10.3390/jcm11092601.

Abstract

Cystic kidney disease (CKD) is a heterogeneous group of genetic disorders and one of the most common causes of end-stage renal disease. Here, we investigate the potential effects of long-term human stem cell treatment on kidney function and the gene expression profile of PKD/Mhm (Cy/+) rats. Human adipose-derived stromal cells (ASC) and human skin-derived ABCB5 stromal cells (2 × 10) were infused intravenously or intraperitoneally monthly, over 6 months. Additionally, ASC and ABCB5-derived conditioned media were administrated intraperitoneally. The gene expression profile results showed a significant reprogramming of metabolism-related pathways along with downregulation of the cAMP, NF-kB and apoptosis pathways. During the experimental period, we measured the principal renal parameters as well as renal function using an innovative non-invasive transcutaneous device. All together, these analyses show a moderate amelioration of renal function in the ABCB5 and ASC-treated groups. Additionally, ABCB5 and ASC-derived conditioned media treatments lead to milder but still promising improvements. Even though further analyses have to be performed, the preliminary results obtained in this study can lay the foundations for a novel therapeutic approach with the application of cell-based therapy in CKD.

摘要

多囊肾病(CKD)是一组异质性的遗传疾病,也是终末期肾病最常见的病因之一。在此,我们研究长期人类干细胞治疗对PKD/Mhm(Cy/+)大鼠肾功能和基因表达谱的潜在影响。人脂肪来源的基质细胞(ASC)和人皮肤来源的ABCB5基质细胞(2×10)在6个月内每月通过静脉或腹腔内注射。此外,腹腔内给予ASC和ABCB5来源的条件培养基。基因表达谱结果显示,代谢相关途径发生了显著的重编程,同时cAMP、NF-κB和凋亡途径下调。在实验期间,我们使用一种创新的非侵入性经皮装置测量了主要的肾脏参数以及肾功能。总体而言,这些分析表明ABCB5和ASC治疗组的肾功能有适度改善。此外,ABCB5和ASC来源的条件培养基治疗导致的改善较轻微但仍有前景。尽管还需要进行进一步分析,但本研究获得的初步结果可为在CKD中应用基于细胞的治疗的新型治疗方法奠定基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eef/9102853/a5f4d7cccf9e/jcm-11-02601-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验